Skip to main content
Atrás
Watch Compare

BioCardia, Inc.

Calidad de datos: 83%
BCDA
NASDAQ Manufacturing Chemicals
$1.18
▲ $0.01 (0.85%)
Cap. Mercado: 12.96 M
Precio
$1.19
Cap. Mercado
12.96 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -7.44 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-2220.78%
Below sector avg (-54.01%)
ROIC-1017.84%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio1.62
Interest CoverageN/A

Valoración

PE (TTM|NTM)
-1.58 | -2.11
Below sector avg (-1.49)
P/B Ratio4.94
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1385 pares)
Métrica Acción Mediana del Sector
P/E -1.6 -1.5
P/B 4.9 1.6
ROE % -2220.8 -54.0
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

2 analistas
Buy
Actual
$1.18
+1213.6%
Objetivo
$15.50
$6.00
$15.50
$25.00
Pronóstico
P/E Futuro -2.11
EPS Futuro -$0.56
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.56
-$0.56 – -$0.56
 0.0 1
FY2026 -$0.71
-$0.71 – -$0.71
 0.0 1

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.20 -$0.06 +70.0%
Q32025 -$0.25 -$0.24 +4.0%
Q22025 -$0.50 -$0.40 +20.0%
Q12025 -$0.39 -$0.59 -51.3%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.23 M
ROE -2220.78% ROA -199.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7.44 M
ROIC -1017.84% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.62
Interest Coverage N/A Asset Turnover N/A
Working Capital 2.06 M Tangible Book Value 2.63 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.58 Forward P/E -2.11
P/B Ratio 4.94 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -57.41%
Market Cap 12.96 M Enterprise Value 7.68 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0.68 OCF / Share -0.68
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 90.46%
SBC-Adj. FCF -7.97 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -8.23 M -7.95 M -11.57 M -11.91 M -12.62 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -8.28 M -8.00 M -11.64 M -11.90 M -12.63 M
EBITDA — — — — —
R&D Expenses 4.96 M 4.39 M 7.73 M 8.83 M 8.56 M
SG&A Expenses 3.32 M 3.67 M 4.40 M 4.42 M 5.09 M
D&A 24,000.0 67,000.0 84,000.0 82,000.0 60,000.0
Interest Expense — — — — 0.0
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.41 M 3.72 M 2.99 M 9.79 M 15.72 M
Total Liabilities 2.52 M 2.89 M 4.59 M 4.90 M 5.34 M
Shareholders' Equity 895,000.0 837,000.0 -1.60 M 4.89 M 10.38 M
Total Debt — — — — —
Cash & Equivalents 2.50 M 2.37 M 1.10 M 7.36 M 12.87 M
Current Assets 2.73 M 2.62 M 1.46 M 7.86 M 13.48 M
Current Liabilities 2.43 M 2.32 M 3.61 M 3.59 M 3.71 M